Coronavirus Disease-2019, Diabetes and Dialysis: An Internal Medicine Conundrum Proposal for a Suitable and Easy-to-Handle Prevention Protocol

Authors

  • Felice Strollo
  • Ersilia Satta
  • Carmine Romano
  • Carmelo Alfarone
  • Teresa D. Corte

DOI:

https://doi.org/10.17140/DROJ-6-147

Keywords:

COVID-19, Dialysis, Diabetes, Prevention Contagion.

Abstract

Frail populations burdened with chronic diseases can get more severe forms of coronavirus disease-2019 (COVID-19) and have a
higher mortality rate. Aim To test the efficacy of a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) containment protocol in patients with endstage renal disease (ESRD) diabetes mellitus (DM) requiring dialysis, who are a typical example of the above category. Methods The protocol included: (i) daily telephone COVID-19 related triage for patients and their general practitioners (GPs); (ii) social distancing; (iii) environment sanitization, including ambulances, transfer vans, medical equipment, patient/health personnel clothing, and individual protection devices; (iv) adoption of quota systems for patients allowed to the dialysis room, and increased time lags among dialysis shifts. Eight hundred twenty-five (825) patients on dialysis (315 with and 510 without DM), and 381 healthcare providers (HCPs) were monitored continuously from the start of the pandemic until the end of the lockdown.
Results No HCPs were infected, while only two patients on dialysis were positive for SARS-CoV-2: one with DM, who died in intensive care, and one without DM, who recovered at home. The adopted contagion containment protocol proved to be effective for both HCPs
and patients. Conclusion Therefore, we propose it as a useful model for any internal medicine or ESRD specialized units dealing with patients on dialysisoriented with or without DM.


References

Conte G. I primi due casi di coronavirus confermati in Ita-lia. Il 2 febbraio l’evacuazione degli italiani da Wuhan, su ANSA, 31 gennaio. [In: Italian]. 2020. Web site. https://www.ansa.it/ canale_saluteebenessere/notizie/sanita/2020/01/30/conte-pri-mi-due-casi-di-coronavirus-confermati-in-italia.-il-2-febbraio-le-vacuazione-degli-italiani-da-wuhan-_3698a086-c24e-470e-bba0- ef010daf4705.html. Accessed October 22, 2020.

. The Department of Health (DOH). WHO DECLARES 2019-NCOV ARD ‘PUBLIC HEALTH EMERGENCY OF IN-TERNATIONAL CONCERN’; PHIL GOV’T ISSUES TRAV-EL BAN. Press Release 31 January, 2020. Web site. https://www. doh.gov.ph/doh-press-release/who-declares-2019-nCoV-ARD-public-health-emergency-of-international-concern. Accessed Oc-tober 22, 2020.

la Repubblica. Cronaca. Web site. https://www.repubblica.it/ cronaca Coronavirus: 14 casi in Lombardia, due positivi ai primi test in Veneto, in la Repubblica, 21 febbraio. [In: Italian]. 2020. Web site. https://www.repubblica.it/cronaca/2020/02/21/ news/coronavirus_casi_veneto-249192220/. Accessed October 22, 2020.

IL MATTINO. Due casi di coronavirus confermati dai primi due test a Padova, in Il Mattino (Padova), 21 febbraio. [In: Italian]. 2020. Web site. https://www.ilmattino.it/primopiano/cronaca/ coronavirus_padova_contagiati_veneto_ultime_notizie-5066356. html. Accessed October 22, 2020.

MILANO/CRONACA Coronavirus, in isolamento Castiglione d’Adda, Codogno, Casalpusterlengo e altri 7 comuni, in Corriere Research Protocol | Volume 6 | Number 2| della Sera (Milano). [In: Italian]. Web site. https://milano.corriere. it/notizie/cronaca/20_febbraio_21/coronavirus-castiglione-d-adda-codogno-isolamento-non-uscite-casa-non-andate-pronto-soccorso-4b0597ee-548e-11ea-9196-da7d305401b7.shtml. Ac-cessed October 22, 2020.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733. doi: 10.1056/NEJMoa2001017

Liu YC, Liao CH, Chang CF, Chou CC and Lin YR. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N Engl J Med. 2020; 382: 1070-1072. doi: 10.1056/NEJMc2001573

Nishiura H, Jung S, Linton NM, Kinoshita R, Yang Y, Hayashi K, et al. The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020. J Clin Med. 2020; 9: 330. doi: 10.3390/ jcm9020330

Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020; 97(5): 824-828. doi: 10.1016/j.kint.2020.03.001

Epidemiology Working Group for NCIP Epidemic Re-sponse, Chinese Center for Disease Control and Prevention. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Disease (COVID-19) – China. 2020. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2): 145-151. doi: 10.3760/cma.j.is sn.0254-6450.2020.02.003

Day M. Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020; 368: m1165. doi: 10.1136/bmj.m1165

World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Web site. https://www.who.int/docs/default-source/coronavi-ruse/who-china-joint-mission-on-covid-19-final-report.pdf. Ac-cessed October 22, 2020.

ISS Report, april 23, 2020. Characteristics of SARS-CoV-2 patients dying in Italy Report based on available data on April 23th, 2020. Istituto Superiore di Sanità. Web site. https://www.epicen-tro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_23_ april_2020.pdf. Accessed October 22, 2020.

Bocci M. Coronavirus, morti 150 camici bianchi. La Repub-blica. 28 maggio. [In: Italian]. 2020. Web site. https://www.repub-blica.it/cronaca/2020/04/25/news/coronavirus_morti_150_ medici-254860106/. Accessed October 22, 2020.

Zhou J, Li C, Zhao G, Chu H, Wang D, Hoi-Ning Yan H, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Science Advances. 2017; 3(11): eaao4966. doi: 10.1126/sciadv.aao4966 Research Protocol | Volume 6 | Number 2| Corte TD et al

Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Character-istic cytokine products of Th1 and Th2 cells in hemodialysis pa-tients. Nephron. 1999; 83(3): 237-245. doi: 10.1159/000045516

Wang R, Liao C, He H, Hu C, Wei Z, Hong Z, et al. CO-VID-19 in hemodialysis patients: A report of 5 cases. Am J Kidney Dis. 2020; 76(1): 141-143. doi: 10.1053/j.ajkd.2020.03.009

Tang B, Li S, Xiong Y, Tian M, Yu J, Xu L, et al. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient. Kidney Med. 2020; 2(3): 354-358. doi: 10.1016/j.xkme.2020.03.001

Rombolà G, Hedemperger M, Pedrini L, Farina M, Aucella F, Messa P, et al. Practical indications for the prevention and man-agement of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. Journal of Ne-phrology. 2020; 33(2): 193-196. doi: 10.1007/s40620-020-00727-y

Ikizler TA. COVID-19 and dialysis units: What do we know now and what should we do? Am J Kidney Dis. 2020; 76(1): 1-3. doi: 10.1053/j.ajkd.2020.03.008

Extance A. Covid-19 and long term conditions: What if you have cancer, diabetes, or chronic kidney disease? BMJ. 2020; 368: m1174. doi: 10.1136/bmj.m1174

de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Him-melfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011; 305(24): 2532-2539. doi: 10.1001/jama.2011.861

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Is-hani A, et al. US Renal data system 2013 annual data report. Am J Kidney Dis. 2014; 63(1 Suppl): A7. doi: 10.1053/j.ajkd.2013.11.001

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Ji Goldstein-Fuchs J, et al. Diabetic kidney disease: A report From an ADA consensus conference. Diabetes Care. 2014; 37(10): 2864- 2883. doi: 10.2337/dc14-1296

Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. 2019 nov-el coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China. Med Rxiv. 2020; 2020. 0224.20027201. doi: 10.1101/2020.02.24.20027201

D’Aria I. Intervista a Fabio Malberti all’Ospedale di Cremo-na del 21 aprile 2020. Coronavirus, i pazienti in dialisi rischia-no di più. La Repubblica. [In: Italian]. Web site. https://www. repubblica.it/salute/medicina-e-ricerca/2020/04/21/news/ coronavirus_i_pazienti_in_dialisi_rischiano_di_piu_ma_con_la_ cura_a_domicilio_meno_covid-positivi-254523027/. Accessed October 22, 2020.

Ronco C, Reis T, De Rosa S. Coronavirus epidemic and ex-tracorporeal therapies in intensive care: si vis pacem para bellum. Blood Purif. 2020; 49(3): 1-4. doi: 10.1159/000507039

Shen Q, Wang M, Che R, Li Q, Zhou J, Wang F, et al. Con-sensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pe-diatr Nephrol. 2020; 35(7): 1351-1357. doi: 10.1007/s00467-020- 04555-x

Kliger AS, Silberzweig J. Mitigating risk of COVID-19 in di-alysis facilities. Clin J Am Soc Nephrol. 2020; 15(5): 707-709. doi: 10.2215/CJN.03340320

Meijers B, Messa P, Ronco C. Safeguarding the maintenance hemodialysis patient population during the coronavirus disease 19 pandemic. Blood Purif. 2020; 49(3): 1-6. doi: 10.1159/000507537

de Sequera Ortiz P, Quiroga Gili B, del a Fuente GA, Macía Heras M, Salgueira Lazo M, del Pino y Pino MD, et al. Protocolo de actuación ante la epidemia de enfermedad porc oronavirus en los pacientes de diálisisy trasplantados renales. [In: Spanish]. Ne-frologia. 2020; 40(3): 253-257. doi: 10.1016/j.nefro.2020.03.001

Wang H. Maintenance hemodialysis and coronavirus disease 2019 (COVID-19): Saving lives with caution, care, and courage. Kidney Med. 2020; 2(3): 365-366. doi: 10.1016/j.xkme.2020.03.003

Chen G, Zhou Y, Zhang L, et al. Core principles for infec-tion prevention in hemodialysis centers during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2020; 1-2. doi: 10.1017/ ice.2020.109

Meijers B, Messa P, Ronco C. Safeguarding the mainte-nance hemodialysis patient population during the coronavi-rus disease 19 pandemic. Blood Purif. 2020; 49(3): 259-264. doi: 10.1159/000507537

BC Renal. HD Infection Control: COVID-19 (WORKING COPY Mar 17, 2020). Guideline: Novel coronavirus (COVID-19) for Hemodialysis Outpatients. Web site. http://www.bcrenala-gency.ca/resource-gallery/Documents/COVID-19_Guideline_ for_Hemodialysis_Programs.pdf. Accessed October 22, 2020.

Arnouts P, Bolignano D, Nistor I. Glucose-lowering drugs in patients with chronic kidney disease: A narrative review on phar-macokinetic properties. Nephrol Dial Transpl. 2014; 29(7): 1284– 1300. doi: 10.1093/ndt/gft462

Guideline development group. Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR45 mL/min). Nephrol Dial Transplant. 2015; 30: 1-142. doi: 10.1093/ndt/gfv100

Adrogue´ HJ. Glucose homeostasis and the kidney. Kidney Int. 1992; 42(5): 1266-1282. doi: 10.1038/ki.1992.414

Xia J, Yin C. Glucose variability and coronary artery dis-ease. Heart Lung Circ. 2019; 28(4): 553-559. doi: 10.1016/j. hlc.2018.10.019 34 Corte TD et al

Ceriello A, Monnier L, Owens D. Glycaemic variability in dia-betes: Clinical and therapeutic implications. Lancet Diabetes Endo-crinol. 2019; 7(3): 221-230. doi: 10.1016/S2213-8587(18)30136-0

Zhou JJ, Schwenke DC, Bahn G, Reaven P. VADT investi-gators glycemic variation and cardiovascular risk in the veterans affairs diabetes trial. Diabetes Care. 2018; 41(10): 2187-2194. doi: 10.2337/dc18-0548

Lo S-C, Yang Y-S, Kornelius E, Huang J-Y, Lai Y-R, Huang C-N, et al. Early cardiovascular risk and all-cause mortality fol-lowing an incident of severe hypoglycaemia: A populationbased cohort study. Diabetes Obes Metab. 2019; 11: 5-9. doi: 10.1111/ dom.13746

International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: Epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019; 7(5): 385-396. doi: 10.1016/s2213-8587(18)30315-2

Park HK. Severe hypoglycemia and cardiovascular disease in type 2 diabetes. Diabetes Metab J. 2015; 39: 478-480. doi: 10.4093/ dmj.2015. 39.6.478

Gentile S, Strollo F, Ceriello A. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experi-ence to be used). Diabetes Res Clin Pract. 2020; 162: 108137. doi: 10.1016/j.diabres.2020.108137

Ceriello A, Stoian AP, Rizzo R. COVID-19 and diabetes management: What should be considered? Diabetes Res Clin Pract. 2020; 163: 108151. doi: 10.1016/j.diabres.2020.108151

Gentile S, Strollo F, Satta E, Corte TD, Romano C, Guarino G, et al. Insulin-related lipohypertrophy in hemodialyzed diabetic people: A multicenter observational study and a methodological approach. Diabetes Ther. 2019; 10(4): 1423-1433. doi: 10.1007/ s13300-019-0650-2

Gentile S, Strollo F, Ceriello A. The need for diabetes care customization in the ICU at the time of SARS-CoV-2 outbreak. Diabetes Ther. 2020; 11(6): 1-3. doi.: 10.1007/s13300-020-00824-y

Perico L, Benigni A, Remuzzi G. Should Covid-19 concern nephrologist? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020; 144(5): 213-221. doi: 10.1159/000507305

Italian Society of Nephrology (SIN). Protocollo CORONA-VIRUS & DIALISI. Web site. https://sinitaly.org/wp-content/ uploads/2020/02/Coronavirus-Dialisi.pdf. Accessed October 22, 2020.

Ministero della Salute. Covid-19-Raccomandazioni per gli operatori sanitari. Web site. http://www.salute.gov.it/portale/ nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lin gua=italiano&id=5373&area=nuovoCoronavirus&menu=vuoto. Research Protocol | Volume 6 | Number 2| Accessed October 22, 2020.

Gentile S, Mambro A, Strollo F. Parallel epidemics, or near-Research Protocol | Volume 6 | Number 2| Corte TD et al ly so: Certainties and uncertainties about SARS-CoV-2 in Italy. Diabetes Res Clin Pract. 2020; 164: 108195.

Downloads

Published

2020-11-04

How to Cite

Felice Strollo, Ersilia Satta, Carmine Romano, Carmelo Alfarone, & Teresa D. Corte. (2020). Coronavirus Disease-2019, Diabetes and Dialysis: An Internal Medicine Conundrum Proposal for a Suitable and Easy-to-Handle Prevention Protocol. Diabetes Research, 6(2), 27–36. https://doi.org/10.17140/DROJ-6-147